| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $37.7M | +2.9% |
| Cost of Revenue | $30.5M | +15.6% |
| Gross Profit | $7.2M | -29.8% |
| R&D Expense | $2.8M | -50.4% |
| SG&A Expense | $23.1M | -9.0% |
| Operating Income | -$26.1M | +26.5% |
| Pre-tax Income | -$26.8M | +27.6% |
| Income Tax | -$88K | +70.5% |
| Net Income | -$26.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.7M | -87.0% |
| Short-term Investments | $26.7M | — |
| Accounts Receivable | $4.3M | +9.2% |
| Inventory | $6.8M | -41.3% |
| Current Assets | $42.8M | -6.3% |
| Total Assets | $118.8M | -7.6% |
| Current Liabilities | $11.2M | +26.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.4M | +34.1% |
| Capital Expenditures | $1.1M | -85.8% |
| Investing Cash Flow | -$27.3M | -252.5% |
| Financing Cash Flow | $14.9M | +16.3% |
| Free Cash Flow | -$13.5M | +49.5% |
| +27.3% |
| EPS (Basic) | -$0.57 | +50.9% |
| EPS (Diluted) | -$0.57 | +50.9% |
| Long-term Debt |
| $9.4M |
| -28.7% |
| Total Liabilities | $36.4M | -5.6% |
| Stockholders' Equity | $82.4M | -8.5% |